SCHEMBL8556311

SCHEMBL8556311

CCN1CC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6360801 0.88 F2 (0.35)
SCHEMBL6362494 0.80
SCHEMBL442261 0.78
SCHEMBL28547061 0.77
SCHEMBL64615 0.75
SCHEMBL12187922 0.75 F2 (0.46)
SCHEMBL12208456 0.75 PIK3CD (0.38)
SCHEMBL5004378 0.75 F2 (0.33)
SCHEMBL16349791 0.75 TOP2A (0.52)
SCHEMBL13798772 0.75 MAPT (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020156323-A1 IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-08-06 WO disclosed
EP-3012258-A1 PYRAZOLO[1,5-A]PYRIMIDINES AND -TRIAZINES AS ANTIVIRAL AGENTS Gilead Sciences, Inc. (US) 2016-04-27 EP disclosed
US-20090227792-A1 HIGHLY REACTIVE a-AMINOMETHYL-ALKOXYSILANES HAVING IMPROVED STABILITY WACKER CHEMIE AG (DE) 2009-09-10 US disclosed
EP-0858451-A1 PHARMACEUTICALLY ACTIVE QUINAZOLINE COMPOUNDS Astra Pharmaceuticals Limited (GB) 1998-08-19 EP disclosed
WO-1997014686-A1 PHARMACEUTICALLY ACTIVE QUINAZOLINE COMPOUNDS ASTRA PHARMACEUTICALS LIMITED (GB) 1997-04-24 WO disclosed